FANC Antibodies

Santa Cruz Biotechnology features a diverse variety of FANC Antibodies for research focused on understanding the Fanconi anemia pathway. FANC Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The Fanconi anemia (FANC) pathway plays a critical role in DNA repair and maintaining genomic stability, making it essential for cellular response to DNA damage. Mutations in FANC proteins are linked to increased susceptibility to cancer and other genetic disorders, highlighting their significance in both basic and clinical research. Understanding FANC protein function can provide insights into the mechanisms of tumorigenesis and potential therapeutic targets. Researchers worldwide rely on FANC pathway studies to advance understanding of DNA repair mechanisms and cancer biology. Current investigations focus on how FANC proteins coordinate with other DNA repair factors to maintain genome integrity. Ongoing research explores the relationship between FANC pathway dysfunction and various cancers. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific knowledge of the Fanconi anemia pathway and its role in human health.